The present invention encompasses compounds of formula (I), wherein the groups R1to R4, R7, A, D, E, F, V, W, X, Y, n, r and q are defined in claim 1, their use as inhibitors of MDM2-p53 interaction, pharmaceutical compositions which contain compounds of this kind, their use as medicaments, especially as agents for treatment and/or prevention of oncological diseases, and synthetic intermediates.本發明包括式(I)化合物, 其中基團R1至R4、R7、A、D、E、F、V、W、X、Y、n、r及q係如技術方案1中所定義,其作為MDM2-p53相互作用之抑制劑之用途,包含此類化合物之醫藥組合物,其作為藥物,尤其作為用於治療及/或預防腫瘤性疾病之藥劑之用途、及合成中間產物。